Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

As A Botanical, Cannabidiol Was Next Ingredient Up For AHPA's Guidance On Use In Supplements

Mar 17 2020

• By Malcolm Spicer

Glass bottle handle, CBD hemp oil. Doctors or researchers hold a bottle of hemp oil. Background with medical stethoscope.medical marijuana concept, CBD cannabis OIL. hemp product, close up

Related Content

FDA ISO Data On CBD Safety In Supplements, Sees Potential As Well As Risks

Nov 20 2019

Confidentiality For Proprietary Information Drives FDA Plan To Generate More CBD Safety Data

Mar 06 2020

FDA's CBD Enforcement Policy Report To Congress May Have Offered More Questions Than Answers

Mar 17 2020

CBD Policies From CHPA, CRN Follow FDA; AHPA Acts Ahead Of Agency

Apr 04 2019

VMS Industry Wants Into CBD Market, Plus Enforcement On Firms Already There

Jun 04 2019

It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims

Jun 25 2018

Related Companies

GW Pharmaceuticals plc

Additional Topics

United States US States Dietary Supplements FDA Regulation Advertising, Marketing & Sales Business Strategies Commercial Compliance Distribution Enforcement Guidance Documents Ingredients Manufacturing Policy Safety Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window